Clinical Trial Results: A Phase 1, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Renal Function and Participants With Renal Impairment. [Phase 1]

View source ↗

Summary

Phase 1 study evaluating LY3502970 in participants with normal renal function and renal impairment; results completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Individuals
• Renal Insufficiency

Drugs mentioned

• LY3502970

Snippet

Sponsor: Eli Lilly and Company | Conditions: Renal Insufficiency, Healthy | Phase 1 | Status: COMPLETED | Results posted: 2026-06-09